In contrast, some studies have shown that activation of the JAK2-STAT3 pathway instead leads to decreased cerebral recovery and that blocking this pathway through the administration of AG490 or a STAT3 siRNA led to improved neurological outcomes such as decreased infarction volume, neuronal damage, and apoptosis42. This evidence concerns the gene JAK2 and infarction.